Gain Therapeutics's total assets for Q3 2024 were $14.37M, a decrease of -25.16% from the previous quarter. GANX total liabilities were $5.46M for the fiscal quarter, a -26.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.